Steven Cohen’s Belite Bio BLTE Stock Holding History

Steven Cohen’s Portfolio BLTE Stock Details BLTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.88M	Buy	+51,186	New	+$7.85M	0.01%	1437
2026 Q1	–	Sell	-284,437	Closed	-$45.5M	–	3804
2025 Q4	$45.5M	Buy	284,437 +281,337	+9,075%	+$33.3M	0.05%	448
2025 Q3	$229K	Buy	3,100 +1,800	+138%	+$118K	﹤0.01%	2111
2025 Q2	$75K	Buy	+1,300	New	+$79.3K	﹤0.01%	2088
2024 Q4	–	Sell	-4,800	Closed	-$225K	–	2092
2024 Q3	$225K	Sell	4,800 -2,511	-34%	-$122K	﹤0.01%	1765
2024 Q2	$334K	Sell	7,311 -1,389	-16%	-$60.1K	﹤0.01%	1521
2024 Q1	$334K	Buy	8,700 +1,000	+13%	+$44.8K	﹤0.01%	1753
2023 Q4	$352K	Buy	+7,700	New	+$296K	﹤0.01%	1664

Other funds holding BLTE

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steven Cohen's BLTE Position: Q2 2026 in Review

Steven Cohen opened a new position in Belite Bio (BLTE) in Q2 2026: 51,186 shares worth $7.88M. The stake represents 0.01% of the portfolio and ranks #1437 among its holdings. This is a return to the name: Steven Cohen previously reported a position in BLTE as recently as Q4 2025.

Steven Cohen first reported a position in BLTE in Q4 2023 and has held it in 8 quarters since. The position peaked at $45.5M in Q4 2025. 81 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

Steven Cohen held 51,186 shares of Belite Bio worth $7.88M as of Q2 2026.
Belite Bio was a new Steven Cohen position in Q2 2026.
Belite Bio made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1437 holding.
Steven Cohen first reported a position in Belite Bio in Q4 2023 and has held it in 8 quarters since.
Steven Cohen's Belite Bio position peaked at $45.5M in Q4 2025.
81 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.